Promise Fulfilled? The next decade of cell, gene and RNA therapies


The 2020s was the era when the full commercial promise of cell, gene and RNA therapies was to be realized – this was only accelerated by the pandemic. Collectively known as advanced therapies, they have the potential to treat numerous diseases. We now are at a pivotal moment; which will see enormous changes to usher cell, gene, and RNA therapies into the pharmacotherapeutic mainstream.

June 07, 2022 | 10:00 AM GMT+01:00

Read More

Next Post

KLAS and Phreesia Partner to Deliver Patient Insights on Healthcare Technology

KLAS, a healthcare research and insights firm, and Phreesia, a leader in patient intake, outreach and activation, are pleased to announce the release of a report that aims to shed light on patients’ preferences and expectations for the technology they interact with as a part of their healthcare experience. The […]